Spirax Group (LON: SPX) Shares Tumble 10% Despite H1 Revenue Rising 5% to £863.8 Million

Spirax Group (LON: SPX) shares fell nearly 10% on Tuesday, August 11, 2026, even as the industrial engineering company reported stronger first-half results. Revenue rose 5% year on year to £863.8 million, while adjusted operating profit increased 8% to £171.1 million. The sell-off came as investors focused on the company’s unchanged full-year outlook. With expectations already high, the market reaction raises a simple question: what did investors see in Spirax Group’s latest results?

Spirax Group H1 2026 Results: Revenue and Profit Both Improve

Revenue reaches £863.8 million

Spirax Group reported a stronger first half on August 11, 2026. Revenue rose 5% year on year to £863.8 million, up from £822.2 million a year earlier. Organic growth also reached 5%, despite weak conditions across the global industry. The company said demand continued to grow faster than industrial production, helping it maintain growth across its customer base.

Adjusted profit and EPS strengthen

Profit grew faster than revenue during the period. Adjusted operating profit increased 8% to £171.1 million, while the adjusted operating margin improved to 19.8% from 19.3%. Adjusted EPS rose 9% to 150.0p. Statutory operating profit also climbed to £154.2 million. The figures point to better margins and stronger operating performance despite the difficult market conditions.

Which Spirax Group Businesses Drove H1 Growth?

Electric Thermal Solutions leads growth

Electric Thermal Solutions delivered the strongest performance among the group’s divisions. Organic revenue rose 11%, helped by continued demand from semiconductor customers. The performance keeps ETS exposed to the ongoing investment cycle in chip manufacturing.

Why Spirax shares are down despite H1 beat:

The specialist engineering group's stock price had run well into the results, while the lack of an upgrade to FY estimates may also have prompted selling.#SPX #GrowthStocks #UKequities #investinghttps://t.co/b8YV8GhnXN pic.twitter.com/YWk836zTRA

— Sharesify (@Sharesify) August 11, 2026

Watson-Marlow benefits from Biopharm demand

Watson-Marlow Fluid Technology Solutions recorded 7% organic growth. Biopharm order intake remained ahead of sales, giving the division a stronger order pipeline heading into the second half.

Steam Thermal Solutions remains resilient

Steam Thermal Solutions posted 1% organic growth, with revenue reaching £419.8 million. Growth was modest, although its performance in China improved from the previous year. The group expects STS growth to pick up in H2 as stronger orders turn into sales.

Why Did Spirax Group Shares Fall 10%?

Investors wanted a stronger full-year outlook

The concern was not a weak set of H1 numbers. Instead, investors were looking for an upgrade to the full-year outlook. Spirax Group kept its guidance for mid-single-digit organic revenue growth and further organic margin improvement. That appears to have disappointed investors who expected the stronger first-half performance to support a higher forecast.

Reuters reported that SPX shares fell 10.5% on August 11, making Spirax one of the biggest drags on the FTSE 100.

Weak industrial production remains a risk

Spirax still operates in markets where industrial demand remains weak. Trade uncertainty and geopolitical tensions could also cause some customers to delay capital spending.

Cash conversion falls

Adjusted cash conversion declined to 54% from 61%. Spirax Group attributed the drop mainly to movements in working capital and inventory. Investors will likely watch cash generation more closely as the year progresses.

Spirax Group Share Price and 2026 Outlook

Spirax shares closed at £76.50 on August 10, just 5% below their 52-week high of £80.50. The results-day sell-off wiped out much of that recent momentum.

Management expects stronger growth across the divisions during H2. Investors will be watching semiconductor demand, Biopharm orders, China’s recovery and margin expansion. The group also needs to show that its unchanged full-year guidance remains achievable in a softer industrial environment.

Spirax Group Stock Forecast: What Investors Should Watch?

Meyka’s platform provides real-time stock research, technical signals, sentiment and forecast tools, but no verified SPX-specific forecast was available through its publicly indexed pages during this search.

The wider analyst view remains constructive. May consensus estimates pointed to £1.758 billion in FY2026 revenue and £360 million in adjusted operating profit. An AI stock analysis tool can help investors track these estimates alongside price momentum.

Conclusion

Spirax Group’s H1 results show that the business continued to grow despite weak industrial conditions. Revenue, profit and EPS all increased, while ETS and WMFTS delivered solid growth. Yet the 10% share-price fall shows that investors were looking for more from management. H2 performance will now come under closer watch. Strong orders and better margins could help rebuild confidence, while unchanged guidance leaves limited room for disappointment.

Disclaimer:

The content shared by Meyka AI PTY LTD is for research and informational purposes only. Meyka is not a financial advisory service, and the information provided should not be treated as investment or trading advice.